Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase*
暂无分享,去创建一个
[1] Hong-Jian Zhu,et al. A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-β Receptor Activation* , 1999, The Journal of Biological Chemistry.
[2] E. Van Obberghen,et al. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. , 1994, The Biochemical journal.
[3] H. Kim,et al. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product. , 1994, The Journal of biological chemistry.
[4] K. Shimokado,et al. Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[5] C. Heldin,et al. Transforming Growth Factor β1 Induces Nuclear Export of Inhibitory Smad7* , 1998, The Journal of Biological Chemistry.
[6] C. Arteaga,et al. Autocrine Transforming Growth Factor-β Signaling Mediates Smad-independent Motility in Human Cancer Cells* , 2003, The Journal of Biological Chemistry.
[7] H. Beug,et al. TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis , 1998, Current Biology.
[8] V. Keshamouni,et al. Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor* , 2004, Journal of Biological Chemistry.
[9] E. Van Obberghen,et al. Insulin stimulates phosphatidylinositol-3-kinase activity in rat adipocytes. , 1992, European journal of biochemistry.
[10] Ying E. Zhang,et al. Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.
[11] L. Chodosh,et al. Conditional Overexpression of Active Transforming Growth Factor β1 In vivo Accelerates Metastases of Transgenic Mammary Tumors , 2004, Cancer Research.
[12] Takeshi Imamura,et al. TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .
[13] C. Downes,et al. Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells. , 1992, The Journal of biological chemistry.
[14] C. Kahn,et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.
[15] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[16] G P Nolan,et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. , 1998, Cancer research.
[17] J. Wrana,et al. The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.
[18] R. Schulte‐Hermann,et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.
[19] H. Moses,et al. Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.
[20] L. Wakefield,et al. TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .
[21] T. Ikeuchi,et al. Insulin Receptor Substrate (IRS)-1 and IRS-2 Are Tyrosine-phosphorylated and Associated with Phosphatidylinositol 3-Kinase in Response to Brain-derived Neurotrophic Factor in Cultured Cerebral Cortical Neurons* , 1997, The Journal of Biological Chemistry.
[22] M. Waterfield,et al. Signaling by distinct classes of phosphoinositide 3-kinases. , 1999, Experimental cell research.
[23] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[24] J. Massagué,et al. GS domain mutations that constitutively activate T beta R‐I, the downstream signaling component in the TGF‐beta receptor complex. , 1995, The EMBO journal.
[25] R. Weinberg,et al. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Campbell,et al. Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. , 2004, Bioorganic & medicinal chemistry letters.
[27] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[28] M. Waterfield,et al. Binding to the Platelet-derived Growth Factor Receptor Transiently Activates the p85α-p110α Phosphoinositide 3-Kinase Complex in Vivo* , 1996, The Journal of Biological Chemistry.
[29] Y. Yarden,et al. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. , 1992, The Journal of biological chemistry.
[30] J. Downing,et al. PDGF, CSF-1, and EGF induce tyrosine phosphorylation of p120, a pp60src transformation-associated substrate. , 1991, Oncogene.
[31] J. Burns,et al. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Hartwig,et al. Signal transduction pathways involving the small G proteins rac and Cdc42 and phosphoinositide kinases. , 1997, Advances in enzyme regulation.
[33] A. Brunet,et al. Transforming Growth Factor (cid:1) Enhances Epithelial Cell Survival via Akt-dependent Regulation of FKHRL1 , 2022 .
[34] N. Hellyer,et al. Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein. , 1995, Gene.
[35] M. White,et al. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity , 1987, Cell.